Retour
Prix Akeso, Inc. (9926.HK)
Graphique du cours de l'action 9926.HK
AKESO (9926.HK)
Akeso, Inc.
HK$121
-1.06%
$-1.29
Marché fermé: Jan 16, 16:00:00 HKT
Statistiques clés
Clôture préc.
$121.9
Prix d'ouverture
$122.3
Plage de la journée
$118.6 - $122.5
Plage de 52 semaines
$55.65 - $179
Volume
5.1M
Volume moyen
6.6M
BPA (TTM)
-1.07
Rendement en dividend
--
Capitalisation boursière
$111.4B
Qu’est-ce que AKESO ?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
